How GLP-1 Receptor Agonists Are Transforming Diabetes Care t2diabetesnetwork Jun 23, 2025 7 min read Updated: May 19 Blog Highlights GLP-1 RAs manage blood sugar and support weight loss for T2D and obesity
PSG estimates that over 5% of the Medicare Part D population is already taking a GLP-1 for diabetes in 2024, and this number could easily double in the coming years
Moreover, the specialized equipment required for pharmaceutical-grade SPPS represents a significant capital investment, and the expertise needed to operate and maintain these systems is concentrated in a relatively small number of contract manufacturing organizations globally
When youre taking GLP-1 medications like Mounjaro or Wegovy, your body processes food and liquids differently, which can make a norovirus infection more challenging to handle: Slower Digestion Wegovy and Mounjaro help you lose weight by intentionally delaying stomach emptying and during a norovirus infection, it may be harder for your stomach to clear the virus, which may drag out the symptoms
Drink in moderation and avoid tobacco use to help prevent oral cancer
Yu W, Sun S, Xu H, Li C, Ren J, Zhang Y